Laura Carrera‐García

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Epilepsy in <i>LAMA2</i>‐related muscular dystrophy: An electro‐clinico‐radiological characterization

Daniel Natera‐de Benito, Jordi Muchart, D. Itzep et al. · Epilepsia · 2020 · 38 citations

Bowel dilation as a predictor of adverse outcome in isolated fetal gastroschisis

Laura Carrera‐García, Maria de Lourdes Brizot, Adolfo Wenjaw Liao et al. · Prenatal Diagnosis · 2010 · 33 citations · Full text

Association of Initial Maximal Motor Ability With Long-term Functional Outcome in Patients With COL6-Related Dystrophies

Daniel Natera‐de Benito, A. Reghan Foley, Cristina Domínguez‐González et al. · Neurology · 2021 · 27 citations · Full text

Salbutamol tolerability and efficacy in patients with spinal muscular atrophy type II

A. Frongia, Daniel Natera‐de Benito, C. Ortez et al. · Neuromuscular Disorders · 2019 · 22 citations

Salbutamol Tolerability, Rehabilitation, Pharmacotherapy +4